olfactory receptor family 2 subfamily H member 5 pseudogeneGenealiases: HS271M21 · OLFR42B · OR2H5 · OR2H7 · OR6-33 · OR6-35
Q-omics provides the consensus-scored OR2H5P profile across patient tissues and cancer cell-line models. OR2H5P expression is associated with patient survival in 15 of 34 cancer types, with the highest sampling consensus in THCA. Among the 18 cancer types available for tumor–normal comparison, OR2H5P is differentially expressed in 2, with the highest sampling consensus in KICH. Additionally, OR2H5P RNA expression shows 7,492 significant gene co-expression associations, with the highest sampling consensus in LIHC. Together, these results highlight THCA, KICH, and LIHC as cancer lineages where OR2H5P shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for OR2H5P — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes OR2H5P survival associations across molecular data types. OR2H5P RNA expression shows survival associations in the most cancer types (15). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible OR2H5P RNA expression–survival associations across cancer types. High OR2H5P expression shows unfavorable associations in THCA, THYM, KIRC and CESC, but favorable associations in LGG and GBM. The THCA Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p < 0.001). Together, the overview and detailed table identify THCA as the clearest survival context for OR2H5P RNA expression.
This table summarizes OR2H5P tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 2. The strongest signals are observed in KICH for RNA.
This table ranks reproducible tumor–normal expression differences for OR2H5P. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. OR2H5P shows lower tumor expression in KICH and higher tumor expression in LUAD. The KICH box plot shows higher OR2H5P RNA expression in normal versus tumor tissue (log2 FC = −0.015, t-test p = .019).
This table shows molecular features associated with OR2H5P in patient tissues and cancer cell lines. In patient samples, OR2H5P shows the broadest associations at the RNA and protein expression levels, with LIHC recurring as the lineage with the largest associated feature set.
